For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240909:nRSI4245Da&default-theme=true
RNS Number : 4245D Assura PLC 09 September 2024
9 September 2024
Assura plc
("the Company")
Notifications of transactions by Persons Discharging Managerial
Responsibilities ("PDMRs")
The Company announces that on 5 September 2024 the following named PDMRs
acquired partnership shares and were awarded matching shares and free shares
over ordinary shares of 10 pence each in the Company under the Company's Share
Incentive Plan ("SIP").
PDMR Position Number of partnership shares acquired Number of matching shares awarded Shareholding of PDMR and PCAs post acquisition and award
Jonathan Murphy CEO 369 431 3,324,816
Jayne Cottam CFO 369 431 949,960
Orla Ball General Counsel 369 431 36,659
Robert James Group Development Director 366 427 27,883
Sarah Taylor Chief People Officer 366 427 17,142
(1) Free share award for all employees as announced in March 2024 Annual
Report and Accounts
The Notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification of dealing form
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Jonathan Murphy
2 Reason for the notification
a) Position/status CEO
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Assura plc
b) LEI 21380026T19N2Y52XF72
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 10 pence each
Identification code
GB00BVGBWW93
b) Nature of the transaction
Acquisition of partnership shares and award of matching shares under the SIP
c) Price(s) and volume(s)
Price(s) Volume(s)
£0.4087 GBP 800
d) Aggregated information
- Aggregated volume
Aggregate Price Aggregate Volume Aggregate Total
- Price
£0.4087 GBP 800 £326.96 GBP
e) Date of the transaction 5 September 2024
f) Place of the transaction XLON
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price Aggregate Volume Aggregate Total
£0.4087 GBP 800 £326.96 GBP
e)
Date of the transaction
5 September 2024
f)
Place of the transaction
XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Jayne Cottam
2 Reason for the notification
a) Position/status CFO
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Assura plc
b) LEI 21380026T19N2Y52XF72
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 10 pence each
Identification code
GB00BVGBWW93
b) Nature of the transaction
Acquisition of partnership shares and award of matching shares under the SIP
c) Price(s) and volume(s)
Price(s) Volume(s)
£0.4087 GBP 800
d) Aggregated information
- Aggregated volume
Aggregate Price Aggregate Volume Aggregate Total
- Price
£0.4087 GBP 800 £326.96 GBP
e) Date of the transaction 5 September 2024
f) Place of the transaction XLON
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price Aggregate Volume Aggregate Total
£0.4087 GBP 800 £326.96 GBP
e)
Date of the transaction
5 September 2024
f)
Place of the transaction
XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Orla Ball
2 Reason for the notification
a) Position/status General Counsel
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Assura plc
b) LEI 21380026T19N2Y52XF72
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 10 pence each
Identification code
GB00BVGBWW93
b) Nature of the transaction
Acquisition of partnership shares and award of matching shares under the SIP
c) Price(s) and volume(s)
Price(s) Volume(s)
£0.4087 GBP 800
d) Aggregated information
- Aggregated volume
Aggregate Price Aggregate Volume Aggregate Total
- Price
£0.4087 GBP 800 £326.96 GBP
e) Date of the transaction 5 September 2024
f) Place of the transaction XLON
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price Aggregate Volume Aggregate Total
£0.4087 GBP 800 £326.96 GBP
e)
Date of the transaction
5 September 2024
f)
Place of the transaction
XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Robert James
2 Reason for the notification
a) Position/status Group Development Director
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Assura plc
b) LEI 21380026T19N2Y52XF72
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 10 pence each
Identification code
GB00BVGBWW93
b) Nature of the transaction
Acquisition of partnership shares and award of matching shares under the SIP
c) Price(s) and volume(s)
Price(s) Volume(s)
£0.4087 GBP 793
d) Aggregated information
- Aggregated volume
Aggregate Price Aggregate Volume Aggregate Total
- Price
£0.4087 GBP 793 £324.10 GBP
e) Date of the transaction 5 September 2024
f) Place of the transaction XLON
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price Aggregate Volume Aggregate Total
£0.4087 GBP 793 £324.10 GBP
e)
Date of the transaction
5 September 2024
f)
Place of the transaction
XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Sarah Taylor
2 Reason for the notification
a) Position/status Chief People Officer
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Assura plc
b) LEI 21380026T19N2Y52XF72
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 10 pence each
Identification code
GB00BVGBWW93
b) Nature of the transaction
Acquisition of partnership shares and award of matching shares under the SIP
c) Price(s) and volume(s)
Price(s) Volume(s)
£0.4087 GBP 793
d) Aggregated information
- Aggregated volume
Aggregate Price Aggregate Volume Aggregate Total
- Price
£0.4087 GBP 793 £324.10 GBP
e) Date of the transaction 5 September 2024
f) Place of the transaction XLON
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price Aggregate Volume Aggregate Total
£0.4087 GBP 793 £324.10 GBP
e)
Date of the transaction
5 September 2024
f)
Place of the transaction
XLON
For more information, please contact:
Assura plc Tel: 0161 515 2043
Orla Ball, General Counsel Email: Investor@assura.co.uk
David Purcell, Investor Relations Director
FGS Global Tel: 0207 251 3801
Gordon Simpson Email: Assura@fgsglobal.com
Notes to Editors
Assura plc is the UK's leading specialist healthcare property investor and
developer. Assura enables better health outcomes through its portfolio of more
than 600 healthcare buildings, from which over six million patients are
served.
A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the
EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7
billion and has a strong track record of growing financial returns and
dividends for shareholders.
At Assura we BUILD for health and as the first FTSE 250 certified B Corp we
are committed to keeping ESG at the heart of our strategy, creating Healthy
Environments (E) and Healthy Communities (S) and maintaining a Healthy
Business (G).
Further information is available at www.assuraplc.com
(http://www.assuraplc.com)
*EPRA is a registered trademark of the European Public Real Estate Association
Assura plc LEI code: 21380026T19N2Y52XF72
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHGCGDCBSGDGSC